FindTrial
Sign In

A clinical trial of tuvarak tail internally and application of its cream locally in human patients of skin disease

Pharmacognostic and clinical study of tuvarak taila(Hydnocarpus Laurifolia) internally and tuvarak Talia malahara locally in management of vatakaphatmak Kustha

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/07/020086
Enrollment
30
Registered
2019-07-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L309- Dermatitis, unspecified

Interventions

Intervention1: Tuvarak Taila(Hydnocarpus laurifolia) internally and Tuvarak Taila malahara Locally: Tuvarak Taila with madhu anupan internally dose-2 ml tuvarak taila with 5 ml of madhu Frequency -Two

Sponsors

Sane guruji arogya kendra
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient showing classical signs and symptoms of vaataj kushta,kaphaj kustha and both symptoms together. symptoms of vataj kustha like dryness,piercing pain,pain,contraction,extension,hardness,horipillation,blackish and reddish roughness symptoms of kaphaj kustha like coldness,itching,rising,heavinees and moisture

Exclusion criteria

Exclusion criteria: any known case of systemic disease pregnant women lactating mother Pittaj Kustha Patient on steriod therapy

Design outcomes

Primary

MeasureTime frame
4 Grades of kandu(Itching) 4 Grades of Rukshana(Dryness) symptoms of vata-kaphatakmak kustha Timepoint: 30 days—

Secondary

MeasureTime frame
1.Size of the lesion 2.Colour of lesion(patch) 3.VAS Scale for Ruja(Pain)Timepoint: 30 days—

Countries

India

Contacts

Public ContactKajalben Pareshkumar shah

Maharashtra university of Health Sciences,Nashik

drkoresharayu@gmail.com9970356590

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026